HP1 promotes tumor suppressor BRCA1 functions during the DNA damage response |
| |
Authors: | Young-Ho Lee Ching-Ying Kuo Jeremy M. Stark Hsiu-Ming Shih David K. Ann |
| |
Affiliation: | 1.Department of Molecular Pharmacology, Beckman Research Institute, City of Hope, Duarte, CA 91010, USA, 2.Irell & Manella Graduate School of Biological Sciences, Beckman Research Institute, City of Hope, Duarte, CA 91010, USA, 3.Division of Radiation Biology, Beckman Research Institute, City of Hope, Duarte, CA 91010, USA and 4.Institute of Biomedical Sciences, Academia Sinica, Taipei 11529, Taiwan, Republic of China |
| |
Abstract: | The DNA damage response (DDR) involves both the control of DNA damage repair and signaling to cell cycle checkpoints. Therefore, unraveling the underlying mechanisms of the DDR is important for understanding tumor suppression and cellular resistance to clastogenic cancer therapeutics. Because the DDR is likely to be influenced by chromatin regulation at the sites of DNA damage, we investigated the role of heterochromatin protein 1 (HP1) during the DDR process. We monitored double-strand breaks (DSBs) using the γH2AX foci marker and found that depleting cells of HP1 caused genotoxic stress, a delay in the repair of DSBs and elevated levels of apoptosis after irradiation. Furthermore, we found that these defects in repair were associated with impaired BRCA1 function. Depleting HP1 reduced recruitment of BRCA1 to DSBs and caused defects in two BRCA1-mediated DDR events: (i) the homologous recombination repair pathway and (ii) the arrest of cell cycle at the G2/M checkpoint. In contrast, depleting HP1 from cells did not affect the non-homologous end-joining (NHEJ) pathway: instead it elevated the recruitment of the 53BP1 NHEJ factor to DSBs. Notably, all three subtypes of HP1 seemed to be almost equally important for these DDR functions. We suggest that the dynamic interaction of HP1 with chromatin and other DDR factors could determine DNA repair choice and cell fate after DNA damage. We also suggest that compromising HP1 expression could promote tumorigenesis by impairing the function of the BRCA1 tumor suppressor. |
| |
Keywords: | |
|
|